NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

They finished automated mfg for Direct according to one of their recent SEC filings. According to the same filing, they have not finished automated mfg for L... as you said.

I wish they had given a hint as to the status of automated mfg for L. Are they still working on it? If not, are they waiting for an imminent efficacy read before deciding to spend more money? If so, you could see why they can't talk about it. But thinking about that brings to mind all sorts of difficult scenarios regarding approval and volume they can't handle, and margins and ... .

Wishful thinking for me would be that they are waiting for early efficacy feedback with a likely outcome of early revenue for a subgroup with high efficacy, and thus high level of reimbursement, that would be profitable without automated mfg for now, and the continuation of the trial for other subgroups, possibly the entire patient population, as they continue working on automated mfg. Of course finishing automated mfg for L also means getting it approved.

This scenario may not be possible since they did not define subgroups, but ignorance is bliss and I am going to ignore those arguments.